BSE Live
Oct 09, 16:01Prev. Close
1410.50
Open Price
1414.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Cash Flow of 3B BlackBio Dx (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 64.00 | 44.33 | 35.31 | 43.22 | 152.04 | |
Net CashFlow From Operating Activities | 43.36 | 26.95 | 22.90 | 37.33 | 97.52 | |
Net Cash Used In Investing Activities | -33.85 | -20.32 | 12.11 | -28.44 | -70.26 | |
Net Cash Used From Financing Activities | -3.22 | -3.63 | -5.01 | -15.07 | -1.57 | |
Foreign Exchange Gains / Losses | 0.39 | -0.07 | 0.30 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 6.69 | 2.94 | 30.31 | -6.19 | 25.70 | |
Cash And Cash Equivalents Begin of Year | 62.15 | 59.21 | 28.89 | 35.08 | 9.38 | |
Cash And Cash Equivalents End Of Year | 68.83 | 62.15 | 59.21 | 28.89 | 35.08 |
05.06.2025
3B BlackBio Dx Standalone March 2025 Net Sales at Rs 23.02 crore, up 4.7% Y-o-Y
03.06.2025
3B BlackBio Dx Consolidated March 2025 Net Sales at Rs 22.50 crore, down 2.19% Y-o-Y
05.03.2025
3B BlackBio Dx Consolidated December 2024 Net Sales at Rs 25.39 crore, up 43.71% Y-o-Y
28.11.2024
3B BlackBio Dx Consolidated September 2024 Net Sales at Rs 29.15 crore, up 52% Y-o-Y
05.06.2025
3B BlackBio Dx Standalone March 2025 Net Sales at Rs 23.02 crore, up 4.7% Y-o-Y
03.06.2025
3B BlackBio Dx Consolidated March 2025 Net Sales at Rs 22.50 crore, down 2.19% Y-o-Y
05.03.2025
3B BlackBio Dx Consolidated December 2024 Net Sales at Rs 25.39 crore, up 43.71% Y-o-Y
28.11.2024
3B BlackBio Dx Consolidated September 2024 Net Sales at Rs 29.15 crore, up 52% Y-o-Y